Key statistics
On Monday, Sonnet Biotherapeutics Holdings Inc (SONN:NAQ) closed at 0.9439, 51.29% above the 52 week low of 0.6239 set on Aug 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.01 |
---|---|
High | 1.01 |
Low | 0.927 |
Bid | 0.73 |
Offer | 1.05 |
Previous close | 1.00 |
Average volume | 80.53k |
---|---|
Shares outstanding | 5.20m |
Free float | 4.92m |
P/E (TTM) | -- |
Market cap | 4.91m USD |
EPS (TTM) | -3.02 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 21:00 BST.
More ▼
- Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
- Sonnet BioTherapeutics Reports Encouraging Data from Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) That Support Advancement into Phase 2 Study
- Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross Proceeds
- Sonnet BioTherapeutics Announces the Generation and Characterization of Two Novel Immunotherapeutic Pipeline Drug Candidates, SON-1411 and SON-1400, Each Containing a Variant IL-18 Domain
- Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting
More ▼